NASDAQ: CCCC
C4 Therapeutics Inc Stock Ownership - Who owns C4 Therapeutics?

Insider buying vs selling

Have C4 Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donna Roy GroganDirector2025-04-019,581$1.44
$13.75kBuy
Kenneth Carl AndersonDirector2025-04-017,841$1.44
$11.25kBuy
Scott N. BoyleChief Business Officer2025-02-18669$3.15
$2.11kSell
Andrew HirschPresident CEO2025-02-159,370$3.18
$29.80kSell
Andrew HirschPresident CEO2025-02-1412,847$3.18
$40.85kSell
Kendra AdamsChief Financial Officer2025-02-144,559$3.18
$14.50kSell
Kelly SchickChief People Officer2025-02-142,368$3.18
$7.53kSell
Jolie SiegelChief Legal Officer2025-02-142,914$3.18
$9.27kSell
Leonard ReynoChief Medical Officer2025-02-145,145$3.18
$16.36kSell
Scott N. BoyleChief Business Officer2025-02-14490$3.15
$1.54kSell

1 of 4

CCCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CCCC insiders and whales buy or sell their stock.

CCCC Shareholders

What type of owners hold C4 Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc A. Cohen11.70%8,308,874$12.55MInsider
Lynx1 Capital Management LP10.00%7,098,133$10.72MInstitution
Soleus Capital Management LP9.83%6,978,942$10.54MInstitution
Orbimed Advisors LLC9.62%6,830,300$10.31MInstitution
Wasatch Advisors LP9.47%6,724,409$10.15MInstitution
Alain J. Cohen8.58%6,094,001$9.20MInsider
Blackrock Inc7.44%5,284,413$7.98MInstitution
Morgan Stanley5.70%4,045,329$6.11MInstitution
Vanguard Group Inc4.75%3,370,880$5.09MInstitution
Samlyn Capital LLC4.25%3,015,139$4.55MInstitution

1 of 3

CCCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CCCC78.03%21.97%Net Selling
ATOS21.95%11.04%Net BuyingNet Buying
CSBR2.00%98.00%Net Buying
THTX27.77%0.00%
TARA47.70%52.30%Net SellingNet Buying

C4 Therapeutics Stock Ownership FAQ

Who owns C4 Therapeutics?

C4 Therapeutics (NASDAQ: CCCC) is owned by 90.27% institutional shareholders, 25.42% C4 Therapeutics insiders, and 0.00% retail investors. Marc A. Cohen is the largest individual C4 Therapeutics shareholder, owning 8.31M shares representing 11.70% of the company. Marc A. Cohen's C4 Therapeutics shares are currently valued at $12.63M.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.